As the main commercialisation company of The University of Queensland, UniQuest’s charter is to identify, package and commercialise university technologies, expertise and facilities to benefit the community, industry and government.

We deliver services via four externally-focused divisions:

• Technology Commercialisation (Techcom)
• ilab business incubator
• Consulting and Research (C&R)
• International Development (ID)

Techcom identifies, packages, protects and manages early stage technologies and innovations for seven research institutions to generate income through royalties, investment and shareholdings.

ilab provides a comprehensive range of services to support a wide range of new technology-driven enterprises, such as networking, education and funding programs for supporting high-growth start-up companies.

C&R brings industry and governments access to The University of Queensland’s expertise and research capabilities.

ID works with agencies such as AusAID, NZAID, the Asian Development Bank and the World Bank to develop solutions and effect real change for under-resourced communities.

 Internationally renowned innovations associated with UniQuest include:

• Cervical cancer vaccine Gardasil
• Magnetic resonance imaging technology company Magnetica
• Drug development company QRx Pharma
• Bioimpedence device company ImpediMed
• Triple P Positive Parenting Program
• Drought-resistant plant marketer Aussie Colours